These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9620990)

  • 41. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1.
    Paillot R; Daly JM; Juillard V; Minke JM; Hannant D; Kydd JH
    Vaccine; 2005 Aug; 23(36):4541-51. PubMed ID: 15913852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.
    Gasper DJ; Neldner B; Plisch EH; Rustom H; Carrow E; Imai H; Kawaoka Y; Suresh M
    PLoS Pathog; 2016 Dec; 12(12):e1006064. PubMed ID: 27997610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
    Hu HM; Winter H; Urba WJ; Fox BA
    J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
    Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
    J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD8 T cell memory in B cell-deficient mice.
    Asano MS; Ahmed R
    J Exp Med; 1996 May; 183(5):2165-74. PubMed ID: 8642326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses.
    Matsumura T; O'Callaghan DJ; Kondo T; Kamada M
    Vet Microbiol; 1996 Feb; 48(3-4):353-65. PubMed ID: 9054131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.
    Connors M; Kulkarni AB; Firestone CY; Holmes KL; Morse HC; Sotnikov AV; Murphy BR
    J Virol; 1992 Dec; 66(12):7444-51. PubMed ID: 1433525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD4+ T cells can protect APC from CTL-mediated elimination.
    Mueller SN; Jones CM; Stock AT; Suter M; Heath WR; Carbone FR
    J Immunol; 2006 Jun; 176(12):7379-84. PubMed ID: 16751382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential of DNA-mediated vaccination for equine herpesvirus 1.
    Ruitenberg KM; Walker C; Wellington JE; Love DN; Whalley JM
    Vet Microbiol; 1999 Aug; 68(1-2):35-48. PubMed ID: 10501160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses.
    Simmons CP; Hussell T; Sparer T; Walzl G; Openshaw P; Dougan G
    J Immunol; 2001 Jan; 166(2):1106-13. PubMed ID: 11145691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC).
    Rudolph J; O'Callaghan DJ; Osterrieder N
    J Vet Med B Infect Dis Vet Public Health; 2002 Feb; 49(1):31-6. PubMed ID: 11911590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.
    Mathew A; Kurane I; Rothman AL; Zeng LL; Brinton MA; Ennis FA
    J Clin Invest; 1996 Oct; 98(7):1684-91. PubMed ID: 8833919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation and characterization of monoclonal antibodies against an attenuated vaccine strain of equine herpesvirus type 1 (EHV-1).
    Meyer H; Hübert PH
    Vet Microbiol; 1988 Sep; 18(1):95-101. PubMed ID: 2847404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK.
    Gyotoku T; Ono F; Aurelian L
    Vaccine; 2002 Jun; 20(21-22):2796-807. PubMed ID: 12034107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain.
    TSUJIMURA K; SHIOSE T; YAMANAKA T; NEMOTO M; KONDO T; MATSUMURA T
    J Vet Med Sci; 2009 Nov; 71(11):1439-48. PubMed ID: 19959893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.